MedChem Express

MedChem Express logo

MedChemExpress has an experienced team of custom synthesis chemists, led by an impressive group of Ph.D.'s. With this team, we have the capability of supporting all kinds of chemistry projects of multiple step syntheses of complex labeled molecules, including metabolites and steroids. Following scientific and technological innovation, challenging traditional thinking, MedChemExpress has always been committed to develop quality products that exceed international standards on cost and reliability, to create the most advanced synthetic route. With high experiences in preparing a large numbers of different biologically active molecules, we provide rapid synthesis of new products. That is why we can consistently deliver your custom synthesis compounds faster than any other company.

Company Website

Product Listing

ISRIB (trans-isomer) 50mg  | ≥98%

MedChem Express

ISRIB (trans-isomer) is a potent inhibitor of PERK with an IC50 of 5 nM. IC50 & Target: IC50: 5 nM (PERK)[1] In Vitro: Trans-ISRIB is 100-fold more potent (IC50=5 nM) than cis-ISRIB (IC50= 600 nM), indicating that the compound’s interaction with its cellular target is stereospecific. ISRIB reduces the viability of cells subjected to PERK-activation […]

More Information Supplier Page

ISRIB (trans-isomer) 100mg  | ≥98%

MedChem Express

ISRIB (trans-isomer) is a potent inhibitor of PERK with an IC50 of 5 nM. IC50 & Target: IC50: 5 nM (PERK)[1] In Vitro: Trans-ISRIB is 100-fold more potent (IC50=5 nM) than cis-ISRIB (IC50= 600 nM), indicating that the compound’s interaction with its cellular target is stereospecific. ISRIB reduces the viability of cells subjected to PERK-activation […]

More Information Supplier Page

Istaroxime 100mg  | ≥98%

MedChem Express

Istaroxime is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition of Na+/K+-ATPase […]

More Information Supplier Page

Istaroxime 50mg  | ≥98%

MedChem Express

Istaroxime is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition of Na+/K+-ATPase […]

More Information Supplier Page

Istaroxime 5mg  | ≥98%

MedChem Express

Istaroxime is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition of Na+/K+-ATPase […]

More Information Supplier Page

Istaroxime 10mg  | ≥98%

MedChem Express

Istaroxime is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition of Na+/K+-ATPase […]

More Information Supplier Page

Istaroxime (hydrochloride) 10mg  | ≥98%

MedChem Express

Istaroxime hydrochloride is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime hydrochloride acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition […]

More Information Supplier Page

Istaroxime (hydrochloride) 5mg  | ≥98%

MedChem Express

Istaroxime hydrochloride is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime hydrochloride acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition […]

More Information Supplier Page

Istaroxime (hydrochloride) 100mg  | ≥98%

MedChem Express

Istaroxime hydrochloride is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime hydrochloride acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition […]

More Information Supplier Page

Istaroxime (hydrochloride) 50mg  | ≥98%

MedChem Express

Istaroxime hydrochloride is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime hydrochloride acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition […]

More Information Supplier Page

Istaroxime (hydrochloride) 10mM/1mL  | ≥98%

MedChem Express

Istaroxime hydrochloride is a potent inhibitor of Na+,K+-ATPase with IC50 of 0.11 μM. IC50 & Target: IC50: 0.11 μM (Na+,K+-ATPase)[1] In Vitro: Istaroxime hydrochloride acting as a positive inotropic compound through the inhibition of the Na+,K+-ATPase[2]. Istaroxime (PST2744) inhibits the Na+/K+-ATPase activity from dog kidney with an IC50 value of 0.43 ± 0.15 μM. Inhibition […]

More Information Supplier Page

Istaroxime hydrochloride 10 mM * 1 mL  | 99.32%

MedChem Express

Istaroxime hydrochloride is a Na+/K+-ATPase inhibitor (IC50=0.11 μM) and a sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator.

More Information Supplier Page

Istaroxime hydrochloride 5 mg  | 99.32%

MedChem Express

Istaroxime hydrochloride is a Na+/K+-ATPase inhibitor (IC50=0.11 μM) and a sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator.

More Information Supplier Page

Istaroxime hydrochloride 10 mg  | 99.32%

MedChem Express

Istaroxime hydrochloride is a Na+/K+-ATPase inhibitor (IC50=0.11 μM) and a sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator.

More Information Supplier Page

Istaroxime hydrochloride 50 mg  | 99.32%

MedChem Express

Istaroxime hydrochloride is a Na+/K+-ATPase inhibitor (IC50=0.11 μM) and a sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator.

More Information Supplier Page

Istaroxime hydrochloride 100 mg  | 99.32%

MedChem Express

Istaroxime hydrochloride is a Na+/K+-ATPase inhibitor (IC50=0.11 μM) and a sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator.

More Information Supplier Page

Istradefylline 10mM/1mL  | ≥98%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease. IC50 & Target: Ki: 2.2 nM (adenosine A2A receptor) In Vitro: Istradefylline has 70-fold greater affinity for the A2AR than the A1 receptor with Ki of 2.2 nM versus 150 nM[1]. […]

More Information Supplier Page

Istradefylline 200mg  | ≥98%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease. IC50 & Target: Ki: 2.2 nM (adenosine A2A receptor) In Vitro: Istradefylline has 70-fold greater affinity for the A2AR than the A1 receptor with Ki of 2.2 nM versus 150 nM[1]. […]

More Information Supplier Page

Istradefylline 500mg  | ≥98%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease. IC50 & Target: Ki: 2.2 nM (adenosine A2A receptor) In Vitro: Istradefylline has 70-fold greater affinity for the A2AR than the A1 receptor with Ki of 2.2 nM versus 150 nM[1]. […]

More Information Supplier Page

Istradefylline 100mg  | ≥98%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease. IC50 & Target: Ki: 2.2 nM (adenosine A2A receptor) In Vitro: Istradefylline has 70-fold greater affinity for the A2AR than the A1 receptor with Ki of 2.2 nM versus 150 nM[1]. […]

More Information Supplier Page

Istradefylline 10mg  | ≥98%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease. IC50 & Target: Ki: 2.2 nM (adenosine A2A receptor) In Vitro: Istradefylline has 70-fold greater affinity for the A2AR than the A1 receptor with Ki of 2.2 nM versus 150 nM[1]. […]

More Information Supplier Page

Istradefylline 50mg  | ≥98%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease. IC50 & Target: Ki: 2.2 nM (adenosine A2A receptor) In Vitro: Istradefylline has 70-fold greater affinity for the A2AR than the A1 receptor with Ki of 2.2 nM versus 150 nM[1]. […]

More Information Supplier Page

Istradefylline 10 mM * 1 mL  | 99.42%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease.

More Information Supplier Page

Istradefylline 10 mg  | 99.42%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease.

More Information Supplier Page

Istradefylline 50 mg  | 99.42%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease.

More Information Supplier Page

Istradefylline 100 mg  | 99.42%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease.

More Information Supplier Page

Istradefylline 200 mg  | 99.42%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease.

More Information Supplier Page

Istradefylline 500 mg  | 99.42%

MedChem Express

Istradefylline is a very potent, selective and orally active adenosine A2A receptor antagonist with Ki of 2.2 nM in experimental models of Parkinson’s disease.

More Information Supplier Page

ISX-9 10mM/1mL  | ≥98%

MedChem Express

ISX-9 is a small molecule inducer of adult neural stem cell differentiation. Target: At 2.5-20 μM, ISX-9 has been shown to dose-dependently trigger neurogenesis and block gliogenesis in adult rat hippocampal stem cells through a calcium-activated signaling pathway dependent on myocyte-enhancer factor 2-dependent gene expression.ISX-9 administered at 20 mg/kg for 12 days to mice has […]

More Information Supplier Page

ISX-9 5mg  | ≥98%

MedChem Express

ISX-9 is a small molecule inducer of adult neural stem cell differentiation. Target: At 2.5-20 μM, ISX-9 has been shown to dose-dependently trigger neurogenesis and block gliogenesis in adult rat hippocampal stem cells through a calcium-activated signaling pathway dependent on myocyte-enhancer factor 2-dependent gene expression.ISX-9 administered at 20 mg/kg for 12 days to mice has […]

More Information Supplier Page

ISX-9 10mg  | ≥98%

MedChem Express

ISX-9 is a small molecule inducer of adult neural stem cell differentiation. Target: At 2.5-20 μM, ISX-9 has been shown to dose-dependently trigger neurogenesis and block gliogenesis in adult rat hippocampal stem cells through a calcium-activated signaling pathway dependent on myocyte-enhancer factor 2-dependent gene expression.ISX-9 administered at 20 mg/kg for 12 days to mice has […]

More Information Supplier Page

ISX-9 50mg  | ≥98%

MedChem Express

ISX-9 is a small molecule inducer of adult neural stem cell differentiation. Target: At 2.5-20 μM, ISX-9 has been shown to dose-dependently trigger neurogenesis and block gliogenesis in adult rat hippocampal stem cells through a calcium-activated signaling pathway dependent on myocyte-enhancer factor 2-dependent gene expression.ISX-9 administered at 20 mg/kg for 12 days to mice has […]

More Information Supplier Page

ISX-9 100mg  | ≥98%

MedChem Express

ISX-9 is a small molecule inducer of adult neural stem cell differentiation. Target: At 2.5-20 μM, ISX-9 has been shown to dose-dependently trigger neurogenesis and block gliogenesis in adult rat hippocampal stem cells through a calcium-activated signaling pathway dependent on myocyte-enhancer factor 2-dependent gene expression.ISX-9 administered at 20 mg/kg for 12 days to mice has […]

More Information Supplier Page

IT1t 5 mg  | Purity Not Available

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM.

More Information Supplier Page

IT1t 10 mg  | Purity Not Available

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM.

More Information Supplier Page

IT1t 25 mg  | Purity Not Available

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM.

More Information Supplier Page

IT1t 50 mg  | Purity Not Available

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM.

More Information Supplier Page

IT1t 100 mg  | Purity Not Available

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM.

More Information Supplier Page

IT1t 10mg  | ≥98%

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows very […]

More Information Supplier Page

IT1t 5mg  | ≥98%

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows very […]

More Information Supplier Page

IT1t 25mg  | ≥98%

MedChem Express

IT1t is a potent CXCR4 antagonist; inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. IC50 & Target: IC50: 2.1 nM (CXCL12/CXCR4 interaction)[1] In Vitro: The CXCR4 is involved in chemotaxis and serves as a coreceptor for T-tropic HIV-1 viral entry and in cancer metastasis. IT1t is a small, drug-like, isothiourea derivative. IT1t shows very […]

More Information Supplier Page